Scinai Immunotherapeutics's market cap is currently $1.21M. The company's EPS TTM is $-3.716; its P/E ratio is 0.27; Scinai Immunotherapeutics is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23
Dec 22
Dec 21
Dec 20
Dec 19
Currency in USD
Scinai Immunotherapeutics Earnings and Revenue History
